Humira and Thoracic vertebral fracture - a phase IV clinical study of FDA data

Summary:

We study 647,817 people who have side effects when taking Humira. Thoracic vertebral fracture is found, especially among people who are female, 60+ old, have been taking the drug for 6 - 12 months, also take Methotrexate and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people take Humira and have Thoracic vertebral fracture. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jul, 16, 2023

647,817 people reported to have side effects when taking Humira.
Among them, 156 people (0.02%) have Thoracic vertebral fracture.

What is Humira?

Humira has active ingredients of adalimumab. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 738,352 Humira users.

What is Thoracic vertebral fracture?

Thoracic vertebral fracture is found to be associated with 977 drugs and 499 conditions by eHealthMe. Currently, we are studying 3,511 people who have Thoracic vertebral fracture.

Number of Humira and Thoracic vertebral fracture reports submitted per year:

$Could Humira cause Thoracic vertebral fracture?$

* Approximation only. Some reports may have incomplete information.

Do you take Humira and have Thoracic vertebral fracture?

Check whether Thoracic vertebral fracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .

Related studies

How severe was Thoracic vertebral fracture and when was it recovered:

Thoracic vertebral fracture in Humira

Expand to all the drugs that have ingredients of adalimumab:

Thoracic vertebral fracture and drugs with ingredients of adalimumab

Alternative drugs to, pros and cons of Humira:

Humira (738,352 reports)

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thoracic vertebral fracture treatments and more:

Thoracic vertebral fracture (3,511 reports)

Common drugs associated with Thoracic vertebral fracture:

All the drugs that are associated with Thoracic vertebral fracture:

Thoracic vertebral fracture (977 drugs)

Common conditions associated with Thoracic vertebral fracture:

Osteoporosis: 812 reports
Rheumatoid arthritis: 265 reports
High blood pressure: 198 reports
Osteoporosis post-menopausal: 157 reports
Depression: 113 reports
Multiple myeloma: 111 reports
Multiple sclerosis: 106 reports

All the conditions that are associated with Thoracic vertebral fracture:

Thoracic vertebral fracture (499 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.